Remission | AZ EpiCentral Global

Skip to main content

EpiCentral updates

If you would like to receive email updates about EpiCentral and information on other related medical education activities sponsored by AstraZeneca, including notifications about new content and upcoming live events, please register below.

First name

Email

Your email address will not be shared or made public and will only be used to send updates on EpiCentral and information on other related medical education activities sponsored by AstraZeneca.

I confirm that I have read, consent and agree to the legal terms and conditions.

I agree to (i) AstraZeneca’s processing of my personal data, including its transfer internationally and to third parties and for the purposes of sending email material, in accordance with AstraZeneca’s Privacy and Cookie policy and (ii) the Website Terms of Use.

Register
Sign in

HOME
ABOUT
- Meet the EpiCreators
- Why focus on the epithelium?
EPIFUNDAMENTALS
PUBLICATIONS
CONGRESS HIGHLIGHTS
Scientific & Resource Library

EPICENTRAL

By clicking on this link, you will be leaving the website. Please ensure that you read the legal and privacy policy sections of any website to which you link.

Cancel Proceed

Fullscreen Content

The following content is best viewed on a desktop and has not been optimised for use on mobile and tablet devices. The content will appear fullscreen.

Exit Proceed

EPICENTRAL

This content is no longer available.

Please explore the EpiCentral website for more educational material and resources.

Close

Pathological changes and symptoms of asthma image

Achieving remission in airway diseases

Next Topic

GI Tract

Discover the epithelial drivers of gastrointestinal health and inflammation

Explore topic

LEGAL NOTICE
PRIVACY POLICY
COOKIE POLICY
COOKIE POLICY
CONTACT US

Veeva ID: Z4-80772 | Date of preparation: February 2026.

© 2025 AstraZeneca. All rights reserved. This information is intended for healthcare professionals only. EpiCentral is sponsored and developed by Amgen and AstraZeneca.

Veeva ID: Z4-80772 | Date of preparation: February 2026.

© 2025 AstraZeneca. All rights reserved. This information is intended for healthcare professionals only. EpiCentral is sponsored and developed by Amgen and AstraZeneca.